Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Progranulin is an evolutionarily conserved secreted glycoprotein essential for normal development, tissue repair/regeneration, neuronal health/protection, immune modulation/inflammation control, with dysregulation contributing directly to major human diseases including frontotemporal dementia/ceroid lipofuscinosis when deficient—and cancer when overexpressed.
Modulates signaling pathways such as MAPK/ERK and PI3K/AKT/GSK3β cascades; interacts with TNFRs, Ephrin-type A receptor 2, Perlecan, and Sortilin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Progranulin (PGRN).